[流西林诱导的低血清症]
Donja G Lansink1,2, Donika Zogaj3, Erwin Veldhuis4
1Ziekenhuisgroep Twente, Almelo.
Nederlands tijdschrift voor geneeskunde
|February 20, 2024
概括
甲可以导致危险的低水平 (低血),可能不会通过标准治疗得到改善. 在使用这种抗生素时,监测是至关重要的,特别是在高剂量时.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
- 临床案例研究临床案例研究
背景情况:
- 甲是一种常用于细菌感染的抗生素.
- 低血或低水平可能是某些药物的严重副作用.
- 感染,如受感染的膝关节置换,可能需要积极的抗生素治疗.
研究的目的:
- 描述一个严重的流西林诱导的低血量病例.
- 为了突出标准补充剂在管理这种并发症方面的潜在不足.
- 为了强调在流西林治疗期间监测水平的重要性.
主要方法:
- 一个68岁的患者病例报告,患有感染的膝关节置换,接受高剂量静脉注射流西林治疗.
- 观察治疗两天后出现的低血.
- 调整抗生素治疗和增加补充剂.
主要成果:
- 尽管患者初步服用补充剂,但患有显著的低血.
- 切换到不同的抗生素和增加剂量导致了积极的临床反应.
- 这表明,克西林是耐火性低血清症的可能原因.
结论:
- 甲可以诱导渐进和危及生命的低血清症.
- 标准补充剂可能不足以纠正这种不良影响.
- 应将血清水平的监测纳入治疗方案中,对接受黄西林的患者,特别是高剂量的患者.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
554
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
554
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
996
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
996
Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381


